DA Davidson Comments on The Clorox Company’s Q4 2024 Earnings (NYSE:CLX)

The Clorox Company (NYSE:CLX) – Equities research analysts at DA Davidson issued their Q4 2024 earnings per share (EPS) estimates for shares of Clorox in a research report issued on Wednesday, May 1st. DA Davidson analyst L. Weiser forecasts that the company will post earnings of $1.41 per share for the quarter. DA Davidson currently has a “Neutral” rating and a $162.00 target price on the stock. The consensus estimate for Clorox’s current full-year earnings is $5.85 per share. DA Davidson also issued estimates for Clorox’s FY2025 earnings at $6.03 EPS.

Clorox (NYSE:CLX) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. Clorox’s quarterly revenue was down 5.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.51 EPS.

A number of other equities analysts have also recently weighed in on the company. Citigroup reduced their price target on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a report on Wednesday. The Goldman Sachs Group initiated coverage on Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 price target for the company. Evercore ISI reduced their price target on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a report on Wednesday. Deutsche Bank Aktiengesellschaft reduced their target price on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Finally, UBS Group reduced their target price on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a report on Wednesday. Four analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. Based on data from MarketBeat, Clorox presently has an average rating of “Hold” and an average price target of $146.43.

Clorox Stock Performance

NYSE CLX opened at $138.23 on Thursday. The stock has a market capitalization of $17.17 billion, a price-to-earnings ratio of 71.62, a PEG ratio of 2.08 and a beta of 0.44. Clorox has a twelve month low of $114.68 and a twelve month high of $176.24. The company has a current ratio of 0.90, a quick ratio of 0.57 and a debt-to-equity ratio of 9.73. The stock has a 50-day moving average of $148.74 and a 200 day moving average of $143.08.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be given a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.47%. Clorox’s dividend payout ratio (DPR) is presently 248.70%.

Institutional Investors Weigh In On Clorox

A number of large investors have recently made changes to their positions in the stock. Choreo LLC grew its position in Clorox by 12.8% in the fourth quarter. Choreo LLC now owns 5,741 shares of the company’s stock worth $819,000 after acquiring an additional 652 shares during the period. abrdn plc grew its position in Clorox by 20.1% in the fourth quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after acquiring an additional 33,135 shares during the period. International Assets Investment Management LLC grew its position in Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after acquiring an additional 481,725 shares during the period. Adage Capital Partners GP L.L.C. purchased a new position in Clorox in the third quarter worth approximately $6,605,000. Finally, Eagle Rock Investment Company LLC purchased a new position in Clorox in the fourth quarter worth approximately $2,940,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.